How to correctly assess mortality benefits in public policies
This paper concerns the difficulty of taking long-term effects on health into account in an economic valuation. Indeed, public decision makers should incorporate the cessation lag between implementation of an abatement policy and achievement of all of the expected mortality-related benefits for any projects involving health impacts. This paper shows how this time lag problem can be handled by proposing two approaches—either in terms of deaths avoided or of life years saved—within a dynamic perspective. The main findings are that long-term health benefits calculated by standard methods and widely applied to adverse health effects should be corrected downwards when incorporated into an economic analysis. The magnitude of correction depends on the discount rate, on technical choices dealing with epidemiology and on the method chosen to assess mortality benefits.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 49 (2006)
Issue (Month): 5 ()
|Contact details of provider:|| Web page: http://www.tandfonline.com/CJEP20|
|Order Information:||Web: http://www.tandfonline.com/pricing/journal/CJEP20|
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Johansson,Per-Olov, 1995. "Evaluating Health Risks," Cambridge Books, Cambridge University Press, number 9780521478786.
- Anna Alberini & Maureen Cropper & Alan Krupnick & Nathalie Simon, 2006.
"Willingness to pay for mortality risk reductions: Does latency matter?,"
Journal of Risk and Uncertainty,
Springer, vol. 32(3), pages 231-245, May.
- Anna Alberini & Maureen Cropper & Alan Krupnick & Nathalie B. Simon, 2004. "Willingness to Pay for Mortality Risk Reductions: Does Latency Matter?," Working Papers 2004.53, Fondazione Eni Enrico Mattei.
- Anna Alberini & Maureen Cropper & Alan Krupnick & Nathalie B. Simon, 2004. "Willingness to Pay for Mortality Risk Reductions: Does Latency Matter?," NCEE Working Paper Series 200401, National Center for Environmental Economics, U.S. Environmental Protection Agency, revised Feb 2004.
- Krupnick, Alan & Alberini, Anna & Simon, Nathalie & Cooper, Maureen, 2004. "Willingness to Pay for Mortality Risk Reductions: Does Latency Matter?," Discussion Papers dp-04-13, Resources For the Future.
- Hugh Gravelle & Dave Smith, 2001. "Discounting for health effects in cost-benefit and cost-effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 587-599.
- Krupnick, Alan & Cropper, Maureen & Alberini, Anna & Simon, Nathalie & Itaoka, Kenshi & Akai, Makoto, 1999. "Mortality Risk Valuation for Environmental Policy," Discussion Papers dp-99-47, Resources For the Future.
- Johannesson, Magnus & Johansson, Per-Olov, 1997. "Quality of life and the WTP for an increased life expectancy at an advanced age," Journal of Public Economics, Elsevier, vol. 65(2), pages 219-228, August.
- Johannesson, Magnus & Johansson, Per-Olov, 1995. "Quality of Life and the WTP for an Increased Life Expectancy at an Advanced Age," SSE/EFI Working Paper Series in Economics and Finance 85, Stockholm School of Economics.
- Viscusi, W Kip & Hakes, Jahn K & Carlin, Alan, 1997. "Measures of Mortality Risks," Journal of Risk and Uncertainty, Springer, vol. 14(3), pages 213-233, May-June.
- Johansson,Per-Olov, 1995. "Evaluating Health Risks," Cambridge Books, Cambridge University Press, number 9780521472852. Full references (including those not matched with items on IDEAS)